Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

被引：0
|
作者：
R. Rizzoli
J. J. Body
A. De Censi
J. Y. Reginster
P. Piscitelli
M. L. Brandi
机构：
[1] Geneva University Hospitals and Faculty of Medicine,Division of Bone Diseases
[2] Université Libre de Bruxelles,Department of Medicine, CHU Brugmann
[3] Galliera Hospital,Division of Medical Oncology
[4] European Institute of Oncology,Division of Cancer Prevention and Genetics
[5] University of Liège,Department of Public Health Science
[6] University of Florence,Department of Internal Medicine
来源：
Osteoporosis International | 2012年 / 23卷
关键词：
Aromatase inhibitors; Bisphosphonates; Bone loss; Breast cancer; Fracture risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2567 / 2576
页数：9
相关论文
共 50 条
  • [1] Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper
    Rizzoli, R.
    Body, J. J.
    De Censi, A.
    Reginster, J. Y.
    Piscitelli, P.
    Brandi, M. L.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (11) : 2567 - 2576
  • [2] Erratum to: Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper
    R. Rizzoli
    J. J. Body
    A. DeCensi
    J. Y. Reginster
    P. Piscitelli
    M. L. Brandi
    [J]. Osteoporosis International, 2012, 23 (11) : 2577 - 2577
  • [3] BONE LOSS IN WOMEN WITH BREAST CANCER TREATED WITH AROMATASE INHIBITORS
    Zodelava, M.
    Tsikhiseli, G.
    Nijaradze, S.
    Tskhovrebashvili, N.
    Tatishvili, N.
    Tskhovrebashvili, M.
    Mamaladze, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S465 - S465
  • [4] In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures
    Wilcken, Nicholas
    Lee, Clara Inkyung
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [5] Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
    Cepa, M.
    Vaz, C.
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2015, 40 (04): : 323 - 330
  • [6] Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women
    不详
    [J]. Drugs & Therapy Perspectives, 2009, 25 (10) : 23 - 26
  • [7] Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
    Hadji, P.
    Aapro, M. S.
    Body, J. J.
    Bundred, N. J.
    Brufsky, A.
    Coleman, R. E.
    Gnant, M.
    Guise, T.
    Lipton, A.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (12) : 2546 - 2555
  • [8] Aromatase inhibitors for prevention of breast cancer in postmenopausal women: a narrative review
    Behan, Lucy Ann
    Amir, Eitan
    Casper, Robert F.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (03): : 342 - 350
  • [9] Bone Health in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors
    Zikan, Vit
    Zimovjanova, Martina
    Petruzelka, Lubos
    Pribylova, Jana
    Cabinakova, Michaela
    Raskova, Maria
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [10] Aromatase inhibitors for breast cancer in postmenopausal women
    Campos, SM
    [J]. ONCOLOGIST, 2004, 9 (02): : 126 - 136
12345